Growth Metrics

Rockwell Medical (RMTI) Gross Profit (2016 - 2026)

Rockwell Medical filings provide 16 years of Gross Profit readings, the most recent being $3.9 million for Q4 2025.

  • On a quarterly basis, Gross Profit rose 6.8% to $3.9 million in Q4 2025 year-over-year; TTM through Dec 2025 was $11.7 million, a 33.11% decrease, with the full-year FY2025 number at $11.7 million, down 33.11% from a year prior.
  • Gross Profit hit $3.9 million in Q4 2025 for Rockwell Medical, up from $2.3 million in the prior quarter.
  • In the past five years, Gross Profit ranged from a high of $6.2 million in Q3 2024 to a low of -$2.2 million in Q4 2021.
  • Median Gross Profit over the past 5 years was $2.3 million (2022), compared with a mean of $2.0 million.
  • Biggest five-year swings in Gross Profit: tumbled 679.48% in 2021 and later skyrocketed 766.03% in 2022.
  • Rockwell Medical's Gross Profit stood at -$2.2 million in 2021, then surged by 204.89% to $2.3 million in 2022, then grew by 22.65% to $2.9 million in 2023, then increased by 26.52% to $3.6 million in 2024, then rose by 6.8% to $3.9 million in 2025.
  • The last three reported values for Gross Profit were $3.9 million (Q4 2025), $2.3 million (Q3 2025), and $2.5 million (Q2 2025) per Business Quant data.